---
document_datetime: 2025-04-30 16:19:18
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/extavia-epar-all-authorised-presentations_en.pdf
document_name: extavia-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.2417138
conversion_datetime: 2025-12-30 09:09:54.217878
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength    | Pharmaceutical form                                   | Route of administration   | Immediate packaging                                                       | Content (concentration)                  | Pack size                                                                   |
|------------------|-------------------|-------------|-------------------------------------------------------|---------------------------|---------------------------------------------------------------------------|------------------------------------------|-----------------------------------------------------------------------------|
| EU/1/08/454/008  | Extavia           | 250 µg / ml | Powder and solvent for solution for injection         | Subcutaneous use          | powder: vial (glass); solvent: pre-filled syringe (glass)                 | powder: 3 ml; solvent: 1.2 ml            | 15 vials + 15 pre-filled syringes (luer lock)                               |
| EU/1/08/454/009  | Extavia           | 250 µg / ml | Powder and solvent for solution for injection         | Subcutaneous use          | powder: vial (glass); solvent: pre-filled syringe (glass)                 | powder: 3 ml; solvent: 1.2 ml authorised | 45 (3 x 15) vials + 45 (3 x 15) pre-filled syringes (luer lock) (multipack) |
| EU/1/08/454/010  | Extavia           | 250 µg / ml | Powder and solvent for solution for injection         | Subcutaneous use          | powder: vial (glass); solvent: pre-filled syringe (glass)                 | powder: 3 ml; solvent: 1.2 ml            | 5 vials + 5 pre-filled syringes (luer lock)                                 |
| EU/1/08/454/011  | Extavia           | 250 µg / ml | Powder and solvent for solution for injection         | Subcutaneous use          | powder: vial (glass); solvent: pre-filled longer                          | powder: 3 ml; solvent: 1.2 ml            | 14 vials + 14 pre-filled syringes (luer lock)                               |
| EU/1/08/454/012  | Extavia           | 250 µg / ml | Powder and solvent for solution for injection         | Subcutaneous use no       | syringe (glass) powder: vial (glass); solvent: pre-filled syringe (glass) | powder: 3 ml; solvent: 1.2 ml            | 42 (3 x 14) vials + 42 (3 x 14) pre-filled syringes (luer lock) (multipack) |
| EU/1/08/454/013  | Extavia           | 250 µg / ml | Powder and solvent for solution for injection product | Subcutaneous use          | powder: vial (glass); solvent: pre-filled syringe (glass)                 | powder: 3 ml; solvent: 1.2 ml            | 14 vials + 15 pre-filled syringes (luer lock)                               |
| EU/1/08/454/014  | Extavia           | 250 µg / ml | Powder and solvent for solution for injection         | Subcutaneous use          | powder: vial (glass); solvent: pre-filled syringe (glass)                 | powder: 3 ml; solvent: 1.2 ml            | 42 (3 x 14) vials + 45 (3 x 15) pre-filled syringes (luer lock) (multipack) |